Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REDAPT Blade Augments

K-Number: K190847 · 2019-10-25

Decision Date2019-10-25
Product CodeLPH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

REDAPT Blade Augments is a medical device manufactured by Smith & Nephew, Inc.. It received FDA 510(k) clearance on 2019-10-25 under approval number K190847. The device is classified under product code LPH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the REDAPT Blade Augments?

REDAPT Blade Augments is a medical device that received FDA 510(k) clearance on 2019-10-25. It is manufactured by Smith & Nephew, Inc.. The 510(k) number is K190847.

When was REDAPT Blade Augments approved by the FDA?

REDAPT Blade Augments received FDA 510(k) clearance on 2019-10-25, under approval number K190847.

What company makes REDAPT Blade Augments?

REDAPT Blade Augments is manufactured by Smith & Nephew, Inc..

What is the FDA product code for REDAPT Blade Augments?

The FDA product code for REDAPT Blade Augments is LPH.

Other Devices by Smith & Nephew, Inc.

View all 107 devices →

Related Devices (Code: LPH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.